Background Patients with hypertrophic cardiomyopathy (HCM) often reduce their physical activity due to concerns about sudden cardiac death. However, objective data on activity patterns in HCM, ...
The presentation will cover data from dose cohorts 1 and 2 of the trial, which is evaluating TN-201, a gene replacement therapy for myosin-binding protein C3-associated hypertrophic cardiomyopathy.
Background: Apical hypertrophic cardiomyopathy (HCM) exhibits substantial heterogeneity in morphology and function. Purpose: To identify clinically meaningful phenotypic clusters using imaging ...
The following slide deck was published by HUTCHMED (China) Limited in conjunction with this event.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback